Table 1

Pharmacotherapy in Alzheimer’s disease51

Severity of Alzheimer’s diseaseStandard recommendation
MildAcetylcholinesterase inhibitors (donepezil, rivastigmine)*
ModerateAcetylcholinesterase inhibitors (donepezil, rivastigmine)* AND/OR
NMDA antagonist (memantine)
SevereAcetylcholinesterase inhibitors (donepezil, rivastigmine)* AND/OR
NMDA antagonist (memantine)

  • *Galantamine was not included because it is no longer marketed in the Philippines.

  • NMDA, N-methyl-D-aspartate.